Loading...
Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient‐derived cell invasion via a novel in vivo tumor model
BACKGROUND: The outcomes for patients with advanced hepatocellular carcinoma (HCC) receiving sorafenib are far from satisfactory because of treatment resistance to sorafenib. However, the exact mechanism of resistance to sorafenib remains unclear and it is valuable to establish a novel mouse model t...
Na minha lista:
| Udgivet i: | Animal Model Exp Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930997/ https://ncbi.nlm.nih.gov/pubmed/31942558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ame2.12085 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|